Related Experiment Videos
NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G
L Ragnarsson1, T Yasuda, R J Lewis
1School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Queensland, Australia.
Journal of Neurochemistry
|December 13, 2005
Summary
Conantokin-G (con-G) and Ala7-conantokin-G (Ala7-Con-G) modulate NMDA receptors differently based on subunit composition. NR2A-containing receptors show potentiation then inhibition, while NR2B-containing receptors are only inhibited by these conantokins.
Area of Science:
- Neuroscience
- Molecular Pharmacology
Background:
- N-methyl-D-aspartate (NMDA) receptors are crucial ion channels involved in synaptic plasticity and neurological disorders.
- Conantokins are peptide modulators of NMDA receptors, with potential therapeutic applications.
Purpose of the Study:
- To investigate the differential effects of conantokin-G (con-G) and Ala7-conantokin-G (Ala7-Con-G) on recombinant NMDA receptors composed of different NR1/NR2 subunit combinations.
- To elucidate how NMDA receptor subunit composition influences conantokin binding affinity and functional responses.
Main Methods:
- Recombinant NMDA receptors (NR1 splice variants and NR2 subunits) were expressed in Xenopus oocytes.
- Two-electrode voltage clamp electrophysiology was used to record NMDA receptor activity.
- Glutamate and conantokin concentration-response relationships were determined under varying conditions.
Main Results:
- Glutamate showed slightly higher affinity for NR2A-containing NMDA receptors compared to NR2B-containing receptors.
- Conantokins displayed biphasic concentration-response curves (potentiation then inhibition) at NR2A-containing NMDA receptors.
- Conantokins exhibited monophasic, inhibitory concentration-response curves at NR2B-containing NMDA receptors.
Conclusions:
- The specific subunit composition of NMDA receptors significantly impacts both glutamate and conantokin affinities.
- The nature of the functional response to conantokins (biphasic vs. monophasic inhibition) is determined by the NMDA receptor's subunit combination.